Inclusive PRO Study

  • Research type

    Research Study

  • Full title

    Inclusive and acceptable patient-reported outcome collection: A mixed methods study

  • IRAS ID

    331274

  • Contact name

    Melanie Calvert

  • Contact email

    m.calvert@bham.ac.uk

  • Sponsor organisation

    University of Birmingham

  • Clinicaltrials.gov Identifier

    NA, NA

  • Duration of Study in the UK

    0 years, 7 months, 2 days

  • Research summary

    Background and rationale
    Patient-reported outcomes (PROs) provide essential safety and tolerability data to inform patient-centred clinical care and regulatory decisions. However, trials using PROs often fail to address cultural and health specificities of populations underserved by research. In research, the result of populations being underserved is that they may not benefit from the valuable PRO data that evidences the risks and benefits of treatment from the patients’ own perspective. When this happens systematically, health data poverty occurs, resulting in the absence of vital evidence relating to these groups when informing clinical care, regulatory decisions, and health policy.

    Aims and objectives
    We are conducting a programme of research to:
    1. Explore the accessibility and acceptability of PRO data collection in research and routine care settings
    2. Explore the barriers and facilitators for PRO data collection in research and routine care settings from the perspective of those who are underserved by research
    3. Formulate solutions to address barriers to patient-reported outcome data collection from groups underserved by research.

    Methods
    We plan to meet these objectives by delivering a survey and carrying out interviews and group discussions with members of the public accessing the main entrance foyers, public spaces, and outpatient clinics in University Hospitals Birmingham (UHB) and Sandwell and West Birmingham Hospitals (SWBH). This can include patients, staff, friends and family of patients.

    Funding
    This study is funded by the National Institute for Health and Care Research Birmingham Biomedical Research Centre (NIHR Birmingham BRC).

  • REC name

    London - Camden & Kings Cross Research Ethics Committee

  • REC reference

    23/PR/1551

  • Date of REC Opinion

    12 Jan 2024

  • REC opinion

    Favourable Opinion